Current role
Mitchell Shirvan
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mitchell Shirvan
Silexion Therapeutics Corp reported in an 8-K filed August 21, 2024 that Mitchell Shirvan was appointed Chief Scientific and Development Officer, effective August 15, 2024.
“Effective as of the Closing, the Board appointed Ilan Hadar, Mirit Horenshtein Hadar, CPA, and Dr. Mitchell Shirvan to serve as Chief Executive Officer, Chief Financial Officer, and Chief Scientific and Development Officer, respectively.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-08-15–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Silexion Therapeutics Corp
Other people whose current roles at this company are on record from its filings.
- Ilan Hadar CEO, Chairman
- Mirit Horenshtein Hadar CFO
- Amnon Peled Board Member
- Avner Lushi Board Member
- Dror Abramov Board Member
- Ilan Levin Board Member
- Ilan Shiloah Board Member
- Ruth Alon Board Member
- Shlomo Noy Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.